quinazolines has been researched along with Cholangitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, NS; Li, FY; Ma, WJ; Mao, H; Shrestha, A; Yang, Q; Zhang, W; Zhou, Y | 1 |
| Cheng, N; de Jong, MC; Jiang, L; Li, F; Li, N; Li, Q; Mao, H; Pawlik, TM; Zhou, Y | 1 |
2 other study(ies) available for quinazolines and Cholangitis
| Article | Year |
|---|---|
Effects of epidermal growth factor receptor inhibitor on proliferative cholangitis in hepatolithiasis.
Topics: Adult; Aged; Bile Ducts; Cholangitis; Collagen Type I; Endoscopy, Digestive System; Epithelium; ErbB Receptors; Female; Gefitinib; Gene Expression; Glucuronidase; Humans; Hyperplasia; Ki-67 Antigen; Lithiasis; Liver Diseases; Male; Middle Aged; Mucin-3; Proliferating Cell Nuclear Antigen; Protein Kinase Inhibitors; Quinazolines | 2015 |
Epidermal growth factor receptor as a target for anti-proliferative treatment of proliferative cholangitis in hepatolithiasis.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cholangitis; Collagen Type I; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; fas Receptor; Fibrosis; Gene Expression; In Situ Nick-End Labeling; Ki-67 Antigen; Lithiasis; Male; Mucin 5AC; Quinazolines; Rats; Rats, Sprague-Dawley; Recurrence; Tyrphostins | 2011 |